SMARCB1 and epithelioid sarcoma: In fact, Li and coworkers reported that over 90% (17/18) of SMARCB1/INI1-negative ES fail to express also PBRM1/BAF180, suggesting a synergic role of these two proteins in ES pathogenesis [97].